Campaigners pushed Pharmac to fund 12 months’ Herceptin for women with HER2-positive breast cancer. Now the data have arrived, and they do not suggest much advantage
GPs in England have been banned from routinely prescribing medicines available over the counter, in a move the NHS hopes will save up to £141 million ($275 million) a year
The New Zealand Organisation for Rare Disorders (NZORD) is calling on the Minister of Health to urgently establish an Orphan Drugs Fund that sits within the Ministry, operating outside PHARMAC’s current legislative requirements
Is Medsafe’s update of guidance for classifying medicines simply a shuffling of deckchairs, wonders Blenheim GP Jim Vause, and who is looking out for consumers?
A NEW breast cancer drug shown to reduce the risk of cancer recurrence will soon be made available in Australia, New Zealand and throughout South-East Asia
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management